Recombinant Human Trappin-2/Elafin Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 1747-PI
Key Product Details
Product Specifications
Source
Ala23-Gln117, with a C-terminal 10-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The IC50 value is <50 nM, as measured under the described conditions.
Formulation, Preparation and Storage
1747-PI
Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Trappin-2/Elafin
Trappin-2 is the human member of the trappin gene family that contains SLPI (1). Trappin-2 consists of an N-terminal transglutaminase substrate domain (residues 23‑60) and a C-terminal four-disulfide core or whey acidic protein (WAP) domain (residues 72‑117). Elafin or ESI (elastase-specific inhibitor) and SKALP (skin‑derived anti‑leucoproteinase) are alternative names for Trappin-2 and reflect its protease targets. However, elafin and SKALP sometimes correspond only to the processed form that contains the C-terminal WAP domain of the molecule, which can be isolated naturally. The recombinant human Trappin-2 corresponds to the full‑length form (residues 23‑117), which migrates as two protein bands under SDS-PAGE due to an unidentified mechanism. In addition to its ability to inhibit human neutrophil elastase, it can also be used as a substrate for transglutaminases.
References
- Schalkwijk, J. et al. (1999) Biochem. J. 340:569.
Long Name
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional Trappin-2/Elafin Products
Product Documents for Recombinant Human Trappin-2/Elafin Protein, CF
Product Specific Notices for Recombinant Human Trappin-2/Elafin Protein, CF
For research use only